ibandronic acid has been researched along with acid phosphatase in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleisch, H; Guenther, HL; Vitté, C | 1 |
de la Fuente, J; Goldman, JM; Karkantaris, C; Meletis, J; Palermos, J; Rahemtulla, A; Terpos, E; Vaiopoulos, G; Viniou, N; Voskaridou, E; Yataganas, X | 1 |
Dimai, HP; Dobnig, H; Fahrleitner-Pammer, A; Hauge, E; Obermayer-Pietsch, BM; Pieber, TR; Pilz, S; Piswanger-Soelkner, JC; Portugaller, RH; Prenner, G; Tscheliessnigg, KH | 1 |
Bauss, F; Caeiro, JR; Dapia, S; De La Piedra, C; Diaz-Curiel, M; Montero, M; Quiroga, I; Rubert, M | 1 |
2 trial(s) available for ibandronic acid and acid phosphatase
Article | Year |
---|---|
Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
Topics: Acid Phosphatase; Aged; Antineoplastic Agents; beta 2-Microglobulin; Biomarkers; Bone Resorption; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Ibandronic Acid; Interleukin-6; Isoenzymes; Male; Middle Aged; Multiple Myeloma; Osteogenesis; Pamidronate; Peptides; Tartrate-Resistant Acid Phosphatase | 2003 |
Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
Topics: Acid Phosphatase; Adult; Antacids; Biomarkers; Bone Density Conservation Agents; Bone Resorption; Calcium Carbonate; Cholecalciferol; Collagen Type I; Diphosphonates; Double-Blind Method; Heart Transplantation; Humans; Ibandronic Acid; Isoenzymes; Lumbar Vertebrae; Male; Middle Aged; Radiography; Spinal Fractures; Tartrate-Resistant Acid Phosphatase; Time Factors; Transplantation, Homologous | 2009 |
2 other study(ies) available for ibandronic acid and acid phosphatase
Article | Year |
---|---|
Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption.
Topics: Acid Phosphatase; Alendronate; Animals; Bone Resorption; Cell Line; Culture Media, Conditioned; Diphosphonates; Endopeptidases; Hot Temperature; Ibandronic Acid; Isoenzymes; Kinetics; Molecular Weight; Osteoblasts; Osteoclasts; Rats; Rats, Wistar; Tartrate-Resistant Acid Phosphatase | 1996 |
Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats.
Topics: Acid Phosphatase; Androgens; Animals; Biomechanical Phenomena; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diphosphonates; Femur; Ibandronic Acid; Isoenzymes; Male; Orchiectomy; Osteocalcin; Peptide Fragments; Procollagen; Rats; Tartrate-Resistant Acid Phosphatase | 2011 |